Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
55M
-
Shares change
-
+2.05M
-
Total reported value, excl. options
-
$7.24B
-
Value change
-
+$272M
-
Put/Call ratio
-
4.45
-
Number of buys
-
92
-
Number of sells
-
-75
-
Price
-
$131.55
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q2 2021
210 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q2 2021.
Ascendis Pharma A/S - ADR (ASND) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55M shares
of 55.6M outstanding shares and own 99.03% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.81M shares), Artisan Partners Limited Partnership (6.43M shares), FMR LLC (5.38M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.06M shares), BAKER BROS. ADVISORS LP (3.54M shares), WELLINGTON MANAGEMENT GROUP LLP (3.43M shares), JANUS HENDERSON GROUP PLC (3.13M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.02M shares), Avoro Capital Advisors LLC (1.9M shares), and EVENTIDE ASSET MANAGEMENT, LLC (1.7M shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.